Literature DB >> 7259998

The indicence of severe pre-eclampsia amongst mothers and mothers-in-law of pre-eclamptics and controls.

A Sutherland, D W Cooper, P W Howie, W A Liston, I MacGillivray.   

Abstract

In order to distinguish between a maternal, fetal or maternal and fetal genetic predisposition towards severe pre-eclampsia, the first pregnancies of 158 mothers and 160 mothers-in-law of pre-eclamptic women and of matched controls were analysed. Fourteen per cent of mothers of pre-eclamptics were found to have had severe pre-eclampsia, confirming previous suggestions that the condition "runs in families', in contrast to only a 3% incidence amongst mothers of controls. The incidence in mothers-in-law of both pre-eclamptics and controls was 4%, in full agreement with a maternal genotype hypothesis and suggesting that the fetal genotype plays, at most, only a minor role in the aetiology of severe pre-eclampsia. The data are in agreement with the hypothesis that a single recessive gene acting in the mother could be responsible for severe pre-eclampsia, but multifactorial inheritance is not ruled out. Mild pre-eclampsia showed no such familial tendency, indicating that the mild and severe forms of pre-eclampsia may represent separate pathological entities.

Entities:  

Mesh:

Year:  1981        PMID: 7259998     DOI: 10.1111/j.1471-0528.1981.tb01304.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  18 in total

Review 1.  Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies.

Authors:  Kirsten Duckitt; Deborah Harrington
Journal:  BMJ       Date:  2005-03-02

2.  An exclusion map for pre-eclampsia: assuming autosomal recessive inheritance.

Authors:  C Hayward; J Livingstone; S Holloway; W A Liston; D J Brock
Journal:  Am J Hum Genet       Date:  1992-04       Impact factor: 11.025

3.  A genomewide linkage study of preeclampsia/eclampsia reveals evidence for a candidate region on 4q.

Authors:  G A Harrison; K E Humphrey; N Jones; R Badenhop; G Guo; G Elakis; J A Kaye; R J Turner; M Grehan; A N Wilton; S P Brennecke; D W Cooper
Journal:  Am J Hum Genet       Date:  1997-05       Impact factor: 11.025

4.  An epidemiological study of the immunogenetic aetiology of pre-eclampsia.

Authors:  B W Alderman; R S Sperling; J R Daling
Journal:  Br Med J (Clin Res Ed)       Date:  1986-02-08

5.  Genetic Predisposition to Dyslipidemia and Risk of Preeclampsia.

Authors:  Cassandra N Spracklen; Audrey F Saftlas; Elizabeth W Triche; Andrew Bjonnes; Brendan Keating; Richa Saxena; Patrick J Breheny; Andrew T Dewan; Jennifer G Robinson; Josephine Hoh; Kelli K Ryckman
Journal:  Am J Hypertens       Date:  2014-12-17       Impact factor: 2.689

Review 6.  Angiotensinogen variants and human hypertension.

Authors:  X Jeunemaitre; A P Gimenez-Roqueplo; J Célérier; P Corvol
Journal:  Curr Hypertens Rep       Date:  1999 Feb-Mar       Impact factor: 5.369

7.  Genetic and environmental influences on birthweight in a sample of Korean twins.

Authors:  Yoon-Mi Hur
Journal:  J Korean Med Sci       Date:  2005-06       Impact factor: 2.153

8.  Genome-wide association study of pre-eclampsia detects novel maternal single nucleotide polymorphisms and copy-number variants in subsets of the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study cohort.

Authors:  Linlu Zhao; Michael B Bracken; Andrew T DeWan
Journal:  Ann Hum Genet       Date:  2013-04-02       Impact factor: 1.670

Review 9.  [Role of the angiotensinogen gene for essential hypertension].

Authors:  E Brand; J Ringel; A M Sharma
Journal:  Herz       Date:  2000-02       Impact factor: 1.740

10.  Genome-wide association study identifies a maternal copy-number deletion in PSG11 enriched among preeclampsia patients.

Authors:  Linlu Zhao; Elizabeth W Triche; Kyle M Walsh; Michael B Bracken; Audrey F Saftlas; Josephine Hoh; Andrew T Dewan
Journal:  BMC Pregnancy Childbirth       Date:  2012-06-29       Impact factor: 3.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.